Esperion Therapeutics
ESPR
ESPR
148 hedge funds and large institutions have $426M invested in Esperion Therapeutics in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 9 closing their positions.
Holders
148
Holders Change
+12
Holders Change %
+8.82%
% of All Funds
2.56%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
22
Increased
59
Reduced
41
Closed
9
Calls
$22.5M
Puts
$4.14M
Net Calls
+$18.4M
Net Calls Change
+$6.78M
Top Buyers
Top Sellers
1 |
1
Millennium Management
New York
|
$11.5M |
2 |
ACM
2
Altium Capital Management
New York
|
$4.42M |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$2.69M |
4 |
DTC
4
Deep Track Capital
Greenwich,
Connecticut
|
$37.8M |
5 |
5
D.E. Shaw & Co
New York
|
$2.35M |